NCT05290415View on ClinicalTrials.gov

Host DNA Methylation for Endometrial Cancer Screening

UnknownOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

March 13, 2022

Primary Completion Date

June 13, 2022

Study Completion Date

September 13, 2022

Conditions
Cancer ScreeningEndometrial CancerDNA MethylationCervical CytologyLiquid BiopsyCohort Study
Interventions
DIAGNOSTIC_TEST

DNA methylation testing

DNA CDO1 and CELF4 methylation testing

Trial Locations (1)

100730

RECRUITING

Lei Li, Beijing

Sponsors
All Listed Sponsors
collaborator

Beijing Qiyuanjuhe Biotechnology Co., Ltd

UNKNOWN

lead

Lei Li

OTHER